Bayer today announced a partnership with Impli, an innovative, deep-tech start-up in precision care. Impli’s goal is to advance women’s health and deliver the first real-time hormone monitoring device – making fertility more accessible, safer and more successful.
With hormones playing a critical role in many of our body’s systems and functions, real-time monitoring can help unlock key insights necessary to make smarter, more precise decisions about a person’s healthcare.
Terms of the partnership were not disclosed, but it is intended to advance early-stage research while exploring a variety of potential use cases for hormone monitoring and providing Impli with access to Bayer’s global innovation ecosystem. The partnership is the result of Impli winning a Bayer-sponsored innovation challenge at the HLTH Europe conference earlier this year.
